Literature DB >> 434947

Methotrexate in Reiter's disease.

E T Owen, M L Cohen.   

Abstract

Three cases of severe Reiter's disease were treated successfully with methotrexate after failure of conservative therapy, including systemic corticosteroids in 2 instances. The usefulness and potential hazards of such therapy are discussed, and some evidence that corticosteroids may aggravate the dermatological manifestations of Reiter's disease is presented.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 434947      PMCID: PMC1000318          DOI: 10.1136/ard.38.1.48

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  8 in total

1.  Methotrexate-induced pneumonitis.

Authors:  H D Sostman; R A Matthay; C E Putman; G J Smith
Journal:  Medicine (Baltimore)       Date:  1976-09       Impact factor: 1.889

Review 2.  Reiter's disease: a review with special attention to cardiovascular and neurologic sequellae.

Authors:  A E Good
Journal:  Semin Arthritis Rheum       Date:  1974       Impact factor: 5.532

3.  Reiter's disease and HL-A 27.

Authors:  D A Brewerton; M Caffrey; A Nicholls; D Walters; J K Oates; D C James
Journal:  Lancet       Date:  1973-11-03       Impact factor: 79.321

4.  HL-A W27--a clue to the diagnosis and pathogenesis of Reiter's syndrome.

Authors:  R Morris; A L Metzger; R Bluestone; P I Terasaki
Journal:  N Engl J Med       Date:  1974-03-07       Impact factor: 91.245

5.  Methotrexate for psoriasis. A new therapeutic schedule.

Authors:  G D Weinstein; P Frost
Journal:  Arch Dermatol       Date:  1971-01

6.  Reiter's disease and the histocompatibility antigen, HL-A 27.

Authors:  H Zachariae; J Friis; H Graudal; A Hjortshøj; F Kissmeyer-Nielsen; A Svejgaard; E Svejgaard; E Zachariae
Journal:  Scand J Rheumatol       Date:  1975       Impact factor: 3.641

Review 7.  Methotrexate.

Authors:  G D Weinstein
Journal:  Ann Intern Med       Date:  1977-02       Impact factor: 25.391

8.  The significance of HL-A W27 in ankylosing spondylitis and Reiter's syndrome with three family studies.

Authors:  R A Cross; R Rigby; R L Dawkins
Journal:  Aust N Z J Med       Date:  1975-04
  8 in total
  5 in total

1.  Methotrexate therapy in rheumatoid arthritis. A two year prospective follow-up.

Authors:  A A Drosos; D Psychos; A P Andonopoulos; S Stefanaki-Nikou; E B Tsianos; H M Moutsopoulos
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

2.  Methotrexate therapy in rheumatoid arthritis. Current status.

Authors:  W S Wilke; A H Mackenzie
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

Review 3.  Hepatotoxicity of methotrexate in rheumatic diseases.

Authors:  S Kevat; M Ahern; P Hall
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

Review 4.  The optimum management of arthropathies.

Authors:  C S Wolfe; G R Hughes
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

5.  The pharmacokinetics of methotrexate and its 7-hydroxy metabolite in patients with rheumatoid arthritis.

Authors:  P Seideman; O Beck; S Eksborg; M Wennberg
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.